Global Locations

Empagliflozin 13C6



Chemical Properties of 'Empagliflozin 13C6'

CAT No. :

CS-O-15165
CAS Registry No. : 864070-44-0(Unlabeled)
Category : Isotope Labelled Compounds



OTHER INFORMATION of 'Empagliflozin 13C6'
Therapeutic : Anti-Diabetic
Therapeutic : Anti-Diabetic
IUPAC Name :(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Smileys :O[C@H]([C@H]1O)[C@@H](O[C@H](CO)[C@H]1O)C2=CC(C[13C]3=[13CH][13CH]=[13C](O[C@H]4CCOC4)[13CH]=[13CH]3)=C(Cl)C=C2
Use Classification :Human drugs -> Jardiance -> EMA Drug Category
Hazard Class :Repr. 2 (75%)
EC Number :620-176-8
UNII :HDC1R2M35U
NCI Thesaurus Code :C158136
RXCUI :1545653
MeSH Entry Terms :1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene
Other Synonyms :Empagliflozin
Removed Synonyms :Empagliflozin [INN]
Label Ingredient : EMPAGLIFLOZIN
NDC Code :0597-0152-07, 0597-0152-30, 0597-0152-37, 0597-0152-70, 0597-0152-90, 0597-0153-07, 0597-0153-30, 0597-0153-37, 0597-0153-70, 0597-0153-90 ... total 65.
Toxicity Summary :Experience with empagliflozin overdose is limited - employ standard symptomatic and supportive measures, as well as gastric decontamination when appropriate. The use of hemodialysis in empagliflozin overdose has not been studied but is unlikely to be of benefit given the drug's relatively high protein-binding.
Protein Binding :Empagliflozin is approximately 86.2% protein-bound in plasma.
Exact Mass :450.1445309
InChI :InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1
InchIKey :OBWASQILIWPZMG-QZMOQZSNSA-N
Canonical SMILES :C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl
Isomeric SMILES :C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
Product Description :Empagliflozin is a C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It has a role as a sodium-glucose transport protein subtype 2 inhibitor and a hypoglycemic agent. It is a C-glycosyl compound, an aromatic ether, a tetrahydrofuryl ether and a member of monochlorobenzenes.
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back


Looking for a discounted price or need more info for 'Empagliflozin 13C6 (CS-O-15165)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.

Looking for a discounted price or need more info for 'Empagliflozin 13C6 (CS-O-15165)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.